Cerevast Therapeutics
Redmond, US · Founded 2009 · Delaware corporation
Healthtech
Founders & leadership
GM
Gerald McMorrowExecutive
AA
Anthony AllenmanExecutive
BA
Bradford A ZakesExecutive
Board
YW
Yuquan WangBoard director
FM
Frederic MollBoard director
PC
Paul ClarkBoard director
Reported raises · per SEC filings
Form D private placements$13.2M disclosed across 2 rounds · 2013–2014
▶$11.4MraisedMar 2015 · 14 investors · Other Health CareRule 506(b)
▶$11.4MraisedMar 2015 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Frederic MollDirector
- Gerald McMorrowExecutive Officer, Director
- Anthony AllenmanExecutive Officer
- Paul ClarkDirector
- Yuquan WangDirector
- Bradford A ZakesExecutive Officer, Director
- Offering amount
- $11.4M
- Amount sold
- $11.4M
- First sale
- Dec 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.8MraisedMar 2014 · 8 investors · Other Health CareRule 506(b)
▶$1.8MraisedMar 2014 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Bradford A ZakesExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $1.8M
- First sale
- Nov 2013
- Incorporated
- Corporation, Delaware, 2009
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Cerevast Therapeutics raised?
- Cerevast Therapeutics has disclosed $13.2M raised across 2 rounds.
- Where is Cerevast Therapeutics headquartered?
- Cerevast Therapeutics is headquartered in Redmond, US.